Histopathology and immunophenotyping of late onset cutaneous manifestations of COVID-19 in elderly patients: Three case reports.
COVID-19
Case report
Cutaneous manifestation
Rash
SARS-CoV-2
T-helper infiltrates
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
16 Jul 2021
16 Jul 2021
Historique:
received:
21
03
2021
revised:
12
05
2021
accepted:
27
05
2021
entrez:
26
7
2021
pubmed:
27
7
2021
medline:
27
7
2021
Statut:
ppublish
Résumé
Several cutaneous manifestations such as urticarial rash, erythematous patches and chilblain-like lesions have been described in young adults with coronavirus disease 2019 (COVID-19) and are present in up to 20% patients, but few reports exist describing histopathological and immunophenotypic characteristics of dermatological lesions in older patients. Our aim was to characterize skin lesions in elderly patients during late stages of COVID-19 from clinical, histological and immunophenotypic perspectives. Three patients, admitted for COVID-19, and who developed cutaneous manifestations underwent skin biopsies. Immunophenotypic analysis for CD20, CD3, CD4 and CD8 was performed on skin biopsies to assess immune cell infiltrates. CD1a was used as a marker of Langerhans cells, and CD31 as a marker of endothelial cells. In the three study patients, cutaneous manifestations were evident in the late-stage of COVID-19 (mean time from the first positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) swab to rash onset was 35 d). Skin biopsies showed a similar pattern of T lymphocyte infiltration in all patients. Indeed, a chronic dermatitis with perivascular lymphocytic infiltrate was observed with predominance of CD3+ T-cell (CD3+). Our study confirms previous reports. Histological and immunophenotypic patterns in our patients confirm results described in the two previous reported experiences. This pattern is similar to what is found in some lympho-proliferative disorders. Therefore, since these findings are non-specific, SARS-CoV-2 infection should be suspected.
Sections du résumé
BACKGROUND
BACKGROUND
Several cutaneous manifestations such as urticarial rash, erythematous patches and chilblain-like lesions have been described in young adults with coronavirus disease 2019 (COVID-19) and are present in up to 20% patients, but few reports exist describing histopathological and immunophenotypic characteristics of dermatological lesions in older patients. Our aim was to characterize skin lesions in elderly patients during late stages of COVID-19 from clinical, histological and immunophenotypic perspectives.
CASE SUMMARY
METHODS
Three patients, admitted for COVID-19, and who developed cutaneous manifestations underwent skin biopsies. Immunophenotypic analysis for CD20, CD3, CD4 and CD8 was performed on skin biopsies to assess immune cell infiltrates. CD1a was used as a marker of Langerhans cells, and CD31 as a marker of endothelial cells. In the three study patients, cutaneous manifestations were evident in the late-stage of COVID-19 (mean time from the first positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) swab to rash onset was 35 d). Skin biopsies showed a similar pattern of T lymphocyte infiltration in all patients. Indeed, a chronic dermatitis with perivascular lymphocytic infiltrate was observed with predominance of CD3+ T-cell (CD3+).
CONCLUSION
CONCLUSIONS
Our study confirms previous reports. Histological and immunophenotypic patterns in our patients confirm results described in the two previous reported experiences. This pattern is similar to what is found in some lympho-proliferative disorders. Therefore, since these findings are non-specific, SARS-CoV-2 infection should be suspected.
Identifiants
pubmed: 34307634
doi: 10.12998/wjcc.v9.i20.5744
pmc: PMC8281404
doi:
Types de publication
Case Reports
Langues
eng
Pagination
5744-5751Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: None declared for all the authors. Dr. Mazzitelli M was supported as PhD student by European Commission (FESR FSE 2014-2020) and by Calabria Region (Italy). European Commission and Calabria Region cannot be held responsible for any use which may be made of information contained therein.
Références
Dermatol Res Pract. 2014;2014:674709
pubmed: 25120565
Travel Med Infect Dis. 2020 Sep - Oct;37:101826
pubmed: 32739472
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e449-e450
pubmed: 32441830
Lancet. 2020 Aug 29;396(10251):598-599
pubmed: 32798450
J Infect. 2020 Sep;81(3):e90-e92
pubmed: 32574567
J Dermatol Sci. 2020 May;98(2):75-81
pubmed: 32381430
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e755-e757
pubmed: 32495368
Lancet Infect Dis. 2021 Jan;21(1):24-25
pubmed: 32437697
Dermatopathology (Basel). 2020 Jun 30;7(1):3-16
pubmed: 32608380
Am J Dermatopathol. 2014 Feb;36(2):153-7
pubmed: 24394302
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417
pubmed: 32172546
J Am Acad Dermatol. 2020 Aug;83(2):687-690
pubmed: 32422225
Indian J Dermatol. 2017 Mar-Apr;62(2):158-167
pubmed: 28400635
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Br J Dermatol. 2020 Sep;183(3):431-442
pubmed: 32479680
Clin Immunol. 2005 Mar;114(3):284-92
pubmed: 15721839
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e252-e254
pubmed: 32294262
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776